298 related articles for article (PubMed ID: 21606294)
1. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact.
Mitsunori Y; Tanaka S; Nakamura N; Ban D; Irie T; Noguchi N; Kudo A; Iijima H; Arii S
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):234-42. PubMed ID: 22399158
[TBL] [Abstract][Full Text] [Related]
6. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
[TBL] [Abstract][Full Text] [Related]
7. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
Kudo M; Hatanaka K; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
[TBL] [Abstract][Full Text] [Related]
8. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.
Kato H; Kanematsu M; Kondo H; Goshima S; Matsuo M; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jan; 19(1):76-81. PubMed ID: 14696223
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
[TBL] [Abstract][Full Text] [Related]
10. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
[TBL] [Abstract][Full Text] [Related]
11. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.
Tanaka H; Iijima H; Higashiura A; Yoh K; Ishii A; Takashima T; Sakai Y; Aizawa N; Iwata K; Ikeda N; Iwata Y; Enomoto H; Saito M; Imanishi H; Hirota S; Fujimoto J; Nishiguchi S
J Gastroenterol; 2014 Apr; 49(4):755-63. PubMed ID: 23720089
[TBL] [Abstract][Full Text] [Related]
12. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
Kudo M; Hatanaka K; Inoue T; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
[TBL] [Abstract][Full Text] [Related]
13. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: A preliminary study.
Nanashima A; Tobinaga S; Abo T; Kunizaki M; Takeshita H; Hidaka S; Taura N; Ichikawa T; Sawai T; Nakao K; Nagayasu T
J Surg Oncol; 2011 Feb; 103(2):152-7. PubMed ID: 21259249
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.
Sugimoto K; Moriyasu F; Saito K; Taira J; Saguchi T; Yoshimura N; Oshiro H; Imai Y; Shiraishi J
J Ultrasound Med; 2012 Apr; 31(4):529-38. PubMed ID: 22441909
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
[TBL] [Abstract][Full Text] [Related]
18. Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.
Nakachi K; Tamai H; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
Cancer Imaging; 2014 Apr; 14(1):7. PubMed ID: 25608454
[TBL] [Abstract][Full Text] [Related]
19. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
[TBL] [Abstract][Full Text] [Related]
20. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.
Inoue T; Kudo M; Maenishi O; Komuta M; Nakashima O; Kojiro M; Maekawa K
AJR Am J Roentgenol; 2009 Mar; 192(3):698-705. PubMed ID: 19234266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
